TTM
$6.28B
YoY change
-51.3%
5Y CAGR
+7.7%
Peak year (2024)
$13.40B
Cumulative net income
$130.09B
Net Income history chart for Abbott Laboratories (ABT) from 1985 to 2025
Latest: $6.52B
Net Income growth chart for Abbott Laboratories (ABT) from 1985 to 2025
Latest: -51.3%
Net Income history table for Abbott Laboratories (ABT) from 1985 to 2025
| 2025 | $6.52B | -51.3% | −$6.88B | ||
| 2024 | $13.40B | +134.2% | +$7.68B | ||
| 2023 | $5.72B | -17.5% | −$1.21B | ||
| 2022 | $6.93B | -2.0% | −$138.00M | ||
| 2021 | $7.07B | +57.3% | +$2.58B | ||
| 2020 | $4.50B | +21.9% | +$808.00M | ||
| 2019 | $3.69B | +55.7% | +$1.32B | ||
| 2018 | $2.37B | +396.4% | +$1.89B | ||
| 2017 | $477.00M | -65.9% | −$923.00M | ||
| 2016 | $1.40B | -68.3% | −$3.02B | ||
| 2015 | $4.42B | +93.7% | +$2.14B | ||
| 2014 | $2.28B | -11.3% | −$292.00M | ||
| 2013 | $2.58B | -56.8% | −$3.39B | ||
| 2012 | $5.96B | +26.1% | +$1.24B | ||
| 2011 | $4.73B | +2.2% | +$101.83M | ||
| 2010 | $4.63B | -19.5% | −$1.12B | ||
| 2009 | $5.75B | +17.7% | +$865.12M | ||
| 2008 | $4.88B | +35.3% | +$1.27B | ||
| 2007 | $3.61B | +110.1% | +$1.89B | ||
| 2006 | $1.72B | -49.1% | −$1.66B | ||
| 2005 | $3.37B | +4.2% | +$136.21M | ||
| 2004 | $3.24B | +17.5% | +$482.62M | ||
| 2003 | $2.75B | -1.4% | −$40.47M | ||
| 2002 | $2.79B | +80.2% | +$1.24B | ||
| 2001 | $1.55B | -44.4% | −$1.24B | ||
| 2000 | $2.79B | +13.9% | +$340.18M | ||
| 1999 | $2.45B | +4.8% | +$111.40M | ||
| 1998 | $2.33B | +12.3% | +$255.30M | ||
| 1997 | $2.08B | +10.5% | +$197.10M | ||
| 1996 | $1.88B | +11.4% | +$193.30M | ||
| 1995 | $1.69B | +11.3% | +$172.02M | ||
| 1994 | $1.52B | +8.4% | +$117.56M | ||
| 1993 | $1.40B | +12.9% | +$160.03M | ||
| 1992 | $1.24B | +13.8% | +$150.30M | ||
| 1991 | $1.09B | +12.7% | +$123.00M | ||
| 1990 | $965.80M | +12.3% | +$106.00M | ||
| 1989 | $859.80M | +14.3% | +$107.80M | ||
| 1988 | $752.00M | +18.9% | +$119.40M | ||
| 1987 | $632.60M | +17.0% | +$92.10M | ||
| 1986 | $540.50M | +16.2% | +$75.20M | ||
| 1985 | $465.30M | — | — |
- 2025$6.52B-51.3%
- 2024$13.40B+134.2%
- 2023$5.72B-17.5%
- 2022$6.93B-2.0%
- 2021$7.07B+57.3%
- 2020$4.50B+21.9%
- 2019$3.69B+55.7%
- 2018$2.37B+396.4%
- 2017$477.00M-65.9%
- 2016$1.40B-68.3%
- 2015$4.42B+93.7%
- 2014$2.28B-11.3%
- 2013$2.58B-56.8%
- 2012$5.96B+26.1%
- 2011$4.73B+2.2%
- 2010$4.63B-19.5%
- 2009$5.75B+17.7%
- 2008$4.88B+35.3%
- 2007$3.61B+110.1%
- 2006$1.72B-49.1%
- 2005$3.37B+4.2%
- 2004$3.24B+17.5%
- 2003$2.75B-1.4%
- 2002$2.79B+80.2%
- 2001$1.55B-44.4%
- 2000$2.79B+13.9%
- 1999$2.45B+4.8%
- 1998$2.33B+12.3%
- 1997$2.08B+10.5%
- 1996$1.88B+11.4%
- 1995$1.69B+11.3%
- 1994$1.52B+8.4%
- 1993$1.40B+12.9%
- 1992$1.24B+13.8%
- 1991$1.09B+12.7%
- 1990$965.80M+12.3%
- 1989$859.80M+14.3%
- 1988$752.00M+18.9%
- 1987$632.60M+17.0%
- 1986$540.50M+16.2%
- 1985$465.30M—
Net Income values are taken from Abbott Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current net income (TTM) is $6.28B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual net income for Abbott Laboratories (ABT) came in at $6.52B – plunged 51.3% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories net income delivered a +7.7% annualised rate; with mixed annual results across the window.
Abbott Laboratories net income peaked at $13.40B in 2024; the latest annual figure is $6.52B in 2025 (51.3% below peak).
The highest annual net income of $13.40B was reported in 2024. The lowest in the available history was $465.30M in 1985.
Abbott Laboratories Net Income by Year
Abbott Laboratories Net Income 2025: $6.52B
In 2025, Abbott Laboratories reported net income of $6.52B, plunged 51.3% below 2024.
Abbott Laboratories Net Income 2024: $13.40B
Abbott Laboratories net income in 2024 was $13.40B, surged 134.2% from 2023. This figure represents the highest annual value in the available history.
Abbott Laboratories Net Income 2023: $5.72B
2023's net income for Abbott Laboratories came in at $5.72B, declined 17.5% below 2022.
Abbott Laboratories Net Income 2022: $6.93B
Abbott Laboratories posted net income of $6.93B in 2022, edged down 2.0% below 2021.
Abbott Laboratories Net Income 2021: $7.07B
Abbott Laboratories net income in 2021 was $7.07B.
See more financial history for Abbott Laboratories (ABT).
Sector peers by Net Income
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation